首页> 外文期刊>Cardiovascular therapeutics >Zofenopril and Ramipril in Combination with Acetyl Salicylic Acid in Postmyocardial Infarction Patients with Left Ventricular Systolic Dysfunction: A Retrospective Analysis of the SMILE-4 Randomized, Double-Blind Study in Diabetic Patients
【24h】

Zofenopril and Ramipril in Combination with Acetyl Salicylic Acid in Postmyocardial Infarction Patients with Left Ventricular Systolic Dysfunction: A Retrospective Analysis of the SMILE-4 Randomized, Double-Blind Study in Diabetic Patients

机译:左芬普利和雷米普利联合乙酰水杨酸治疗左室收缩功能障碍的心肌梗死后患者:SMILE-4随机,双盲糖尿病患者的回顾性分析

获取原文
获取原文并翻译 | 示例
           

摘要

ObjectiveIn the SMILE-4 study, zofenopril+acetyl salicylic acid (ASA) was more effective than ramipril+ASA on 1-year prevention of major cardiovascular events (MACE) in patients with acute myocardial infarction complicated by left ventricular dysfunction. In this retrospective analysis, we evaluated drug efficacy in subgroups of patients, according to a history of diabetes mellitus.
机译:目的在SMILE-4研究中,对于急性心肌梗死并发左心功能不全的患者,在预防1年主要心血管事件(MACE)方面,佐芬普利+乙酰水杨酸(ASA)比雷米普利+ ASA更有效。在这项回顾性分析中,我们根据糖尿病史评估了患者亚组的药物疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号